Invention Grant
- Patent Title: Glycan therapeutics and method of treating conditions associated with TMAO
-
Application No.: US16883107Application Date: 2020-05-26
-
Publication No.: US11229660B2Publication Date: 2022-01-25
- Inventor: Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
- Applicant: Kaleido Biosciences, Inc.
- Applicant Address: US MA Lexington
- Assignee: Kaleido Biosciences, Inc.
- Current Assignee: Kaleido Biosciences, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K31/702
- IPC: A61K31/702 ; A61K45/06 ; A61K31/716 ; A61K31/733 ; A61P1/00 ; A61K31/09 ; A61K31/11 ; A61K31/12 ; A61K31/165 ; A61K31/34 ; A61K31/353 ; A61K31/365 ; A61K31/366 ; A61K31/7034 ; A61K31/7048 ; A61K31/706 ; A61K31/715 ; A23L33/10 ; A23P10/00 ; A61K31/7004 ; A61K31/7016 ; A61K35/741 ; A61K35/00
Abstract:
Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
Public/Granted literature
- US20210113596A1 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF Public/Granted day:2021-04-22
Information query
